These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32798993)

  • 1. Prognosis of Macrophage Density in the Absence of Neutrophils in Differentiated Thyroid Cancer.
    Onuma AE; Schoenfield L; Shen C; Edwards C; Phay JE; Shirley LA; Tsung A
    J Surg Res; 2020 Dec; 256():458-467. PubMed ID: 32798993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrence and Complications in Pediatric and Adolescent Papillary Thyroid Cancer in a High-Volume Practice.
    Rubinstein JC; Herrick-Reynolds K; Dinauer C; Morotti R; Solomon D; Callender GG; Christison-Lagay ER
    J Surg Res; 2020 May; 249():58-66. PubMed ID: 31923715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.
    Chereau N; Dauzier E; Godiris-Petit G; Noullet S; Brocheriou I; Leenhardt L; Buffet C; Menegaux F
    Langenbecks Arch Surg; 2018 May; 403(3):325-332. PubMed ID: 29445865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiated Thyroid Cancer: The Role of ATA Nodal Risk Factors in N1b Patients.
    Taboni S; Paderno A; Giordano D; Albano D; Piana S; Zanetti E; Bertagna F; Grammatica A; Ghidini A; Cappelli C; Bozzola A; Baronchelli C; Nicolai P; Lombardi D
    Laryngoscope; 2021 Mar; 131(3):E1029-E1034. PubMed ID: 33319385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of
    Yang L; Zhang X; Zhang J; Liu Y; Ji T; Mou J; Fang X; Wang S; Chen J
    Future Oncol; 2022 Jan; 18(3):333-348. PubMed ID: 34756116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
    Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the Recurrence and Survival of Patients with Symptomatic and Asymptomatic Papillary Thyroid Carcinoma: An Observational Study of 11,265 Person-Years of Follow-Up.
    Kim SH; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Thyroid; 2016 Oct; 26(10):1472-1479. PubMed ID: 27457917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3.
    Zhou Z; Wang P; Sun R; Li J; Hu Z; Xin H; Luo C; Zhou J; Fan J; Zhou S
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33692217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The extent of lymph node yield in central neck dissection can be affected by preoperative and intraoperative assessment and alter the prognosis of papillary thyroid carcinoma.
    Hu JQ; Wen D; Ma B; Zhang TT; Liao T; Shi X; Wang YL; Zhu YX; Wang Y; Wei WJ; Ji QH
    Cancer Med; 2020 Feb; 9(3):1017-1024. PubMed ID: 31854077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Matrix metalloproteinase-9 (MMP-9) can help identify patients with papillary thyroid cancer at high risk of persistent disease: Value and limitations of a potential marker of neoplasia.
    Dobrescu R; Picu C; Caragheorgheopol A; Manda D; Ioachim D; Goldstein A; Badiu C
    Cancer Biomark; 2020; 29(3):337-346. PubMed ID: 32716342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age, thyroglobulin levels and ATA risk stratification predict 10-year survival rate of differentiated thyroid cancer patients.
    Kelly A; Barres B; Kwiatkowski F; Batisse-Lignier M; Aubert B; Valla C; Somda F; Cachin F; Tauveron I; Maqdasy S
    PLoS One; 2019; 14(8):e0221298. PubMed ID: 31425569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Increased Neutrophil-to-Lymphocyte Ratio Predicts Incomplete Response to Therapy in Differentiated Thyroid Cancer.
    Lee F; Yang PS; Chien MN; Lee JJ; Leung CH; Cheng SP
    Int J Med Sci; 2018; 15(14):1757-1763. PubMed ID: 30588200
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma.
    Abd Allah MYY; Fahmi MW; El-Ashwah S
    J Egypt Natl Canc Inst; 2020 Apr; 32(1):18. PubMed ID: 32372254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases.
    Matsuzu K; Sugino K; Masudo K; Nagahama M; Kitagawa W; Shibuya H; Ohkuwa K; Uruno T; Suzuki A; Magoshi S; Akaishi J; Masaki C; Kawano M; Suganuma N; Rino Y; Masuda M; Kameyama K; Takami H; Ito K
    World J Surg; 2014 Jan; 38(1):68-79. PubMed ID: 24081532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased mortality in patients with differentiated thyroid cancer associated with Graves' disease.
    Pellegriti G; Mannarino C; Russo M; Terranova R; Marturano I; Vigneri R; Belfiore A
    J Clin Endocrinol Metab; 2013 Mar; 98(3):1014-21. PubMed ID: 23348395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of low-dose and high-dose postoperative radioiodine therapy on the clinical outcome in patients with small differentiated thyroid cancer having microscopic extrathyroidal extension.
    Han JM; Kim WG; Kim TY; Jeon MJ; Ryu JS; Song DE; Hong SJ; Shong YK; Kim WB
    Thyroid; 2014 May; 24(5):820-5. PubMed ID: 24328997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-Monocyte Ratio Significantly Predicts Recurrence in Papillary Thyroid Cancer.
    Yokota M; Katoh H; Nishimiya H; Kikuchi M; Kosaka Y; Sengoku N; Watanabe M; Yamashita K
    J Surg Res; 2020 Feb; 246():535-543. PubMed ID: 31711613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.
    McLeod DS; Cooper DS; Ladenson PW; Ain KB; Brierley JD; Fein HG; Haugen BR; Jonklaas J; Magner J; Ross DS; Skarulis MC; Steward DL; Maxon HR; Sherman SI;
    Thyroid; 2014 Jan; 24(1):35-42. PubMed ID: 23731273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW; Calsolari MR
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.